Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Amphibian extinction crisis
Jordan to run for speaker
Address blacklisted, man dies
McCarthy's political journey
Next speaker of the House?
Apologizes for lewd gesture
Bridge closed due to protest
$9B student loan forgiveness
Addresses Kerdiles' death
‘Never take life for granted'
Criticizes oil & gas companies
7.5M chickens culled in SA
Protests war in UKR, jailed
2 dead in tragic plane crash
Laurence Fox arrested
Winning numbers drawn
75K+ workers on strike
To pay $1M+ in legal fees
Western allies out of ammo?
Indonesia online retail ban
Retiree group sues NC
Secura air fryers recalled
Thai mall shooter charged
New return package feature
Breast cancer awareness
Philippe heads to Bermuda
Crane topples, 1 dead
Oil falls $1 on demand fears
RU foils UKR drone attack
35th birthday celebration
Open up about rumored affair
Crackdown on illegal migrants
Canada's 1st Black speaker
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
298,000 results
Opinion
3hOpinion
Why is Medicare rationing Alzheimer's drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer's disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
朝日新聞社4d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
WISH-TV
6d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
WNDU13d
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
(WNDU) - More than six million Americans are living with Alzheimer’s disease; it slowly steals your memories and takes away your mind. There is no cure yet, but now, a newly FDA-approved drug is ...
Morningstar6d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition ...
GEN
1d
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Morningstar analyst Karen Andersen, CFA, discusses a recent report by her firm about the challenges faced by biopharma with ...
Benzinga.com8d
Alzheimer's disease Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)
DelveInsight’s, “Alzheimer’s Disease Pipeline Insights 2023” report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in Alzheimer’s Disease pipeline landscape.
Salon20d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
Journal Record
21h
FDA proposes new regulation of lab tests
The Food and Drug Administration has laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar ...
News4Jax6d
First FDA approved drug to slow Alzheimer’s
More than 6 million Americans are living with Alzheimer’s disease. It slowly steals your memories and takes away your mind. There is no cure, yet, but now, a newly FDA-approved drug is helping ...
Afro22d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
Business Wire6d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices